US 2021/0070809 A1Published application

Novel antibacterial protein efal-2 having bacteriolytic ability with respect to enterococcus faecium

AssigneeIntron Biotechnology, Inc.

InventorsSeong Jun Yoon, Myung Soo Kang, Soo Youn Jun, Jong Hyun Kim, Gi Mo Jung, Jee Soo Son, Hyoun Rok Paik, Sang Hyeon Kang

Life of this patent

Estimating the term…

patentgrep

Loading patent…

Abstract

The present invention relates to an antibacterial protein EFAL-2 derived from bacteriophage Ent-FAP-4 (Accession number: KCTC 12854BP), which has the ability to kill Enterococcus faecium and an amino acid sequence represented by SEQ ID NO: 2, a pharmaceutical composition containing the same as an active ingredient, and a method for preventing or treating diseases caused by Enterococcus faecium using the pharmaceutical composition.

Claims6

Dependent claims

-10. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 17/100,232Filed 20 Nov 2020
Priority: KR 10-2017-002332022 Feb 2017
Published: 11 Mar 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents
C12N 15/70
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression: vectors or expression systems…
A61K 38/00
Medicinal preparations containing peptides

Family

Application16/487,508Division · filed 21 Aug 2019
Application17/100,232Division
US 11,492,378 B2Related patent
US 2020/0055902 A1Published application
US 2021/0070809 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key